Other substances

Sodium pyruvate

Phase of research

Potential treatment - theoretical effect

How it helps

Other treatment

Drug status

Used to treat other disease

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Supporting references

Link	Tested on	Impact factor	Notes	Publication date
Inhaled Nebulized Sodium Pyruvate Use in COVID-19 Patients	Theory only			May/09/2020

Clinical trials

ID	Title	Status	Phase	Start date	Completion date
NCT04871815	Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.	Completed	Phase 2\|Phase 3	Apr/27/2021	Mar/07/2022
Alternative id - CSI-COVID-19_009 Interventions - Drug: sodium pyruvate nasal spray Study type - Interventional Study results - Has Results Locations - Missouri State University, Springfield, Missouri, United States Study designs - Allocation: N/A\|Intervention Model: Single Group Assignment\|Masking: None (Open Label)\|Primary Purpose: Treatment Enrollment - 22 Age - 18 Years to 40 Years (Adult) Outcome measures - Change in the Symptoms of Long COVID-19 Patients\|Change in Body Temperature in Long COVID-19 Patients\|Change in Pulse Rate in Long COVID-19 Patients\|Change in Blood Oxygenation in Long COVID-19 Patients
NCT04824365	Sodium Pyruvate Nasal Spray Treatment of COVID-19 and Influenza Infections	Recruiting	Phase 2\|Phase 3	Apr/12/2021	Jun/01/2022
Alternative id - CSI-COVID-19_007 Interventions - Drug: Sodium Pyruvate\|Other: Saline Study type - Interventional Study results - No Results Available Locations - Family First Medical Research Center, Virginia Gardens, Florida, United States\|Missouri State University, Springfield, Missouri, United States Study designs - Allocation: Randomized\|Intervention Model: Parallel Assignment\|Masking: Triple (Participant, Care Provider, Outcomes Assessor)\|Primary Purpose: Treatment Enrollment - 60 Age - 18 Years to 40 Years (Adult) Outcome measures - Evaluate the ability of inhaled nasal sodium pyruvate to change COVID-19 or influenza viral titers.\|Evaluate the ability of inhaled nasal sodium pyruvate to change the symptoms of COVID-19 or influenza.